The restored landmark establishment has graced the corner of London and Washington streets in Olde Towne Portsmouth since ...

Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, announced today the receipt of a $50 million installment payment related to the Company’s ...

Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering and rational drug design ...

SPR206 is an investigational, intravenously administered next-generation polymyxin that has shown antibiotic activity against ...

Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited) ...

The revitalization of this 104-year-old building in downtown Cambridge will preserve the city’s proud heritage while focusing ...

Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55%MACI Full-Year 2024 Revenue Growth of 20%, with Fourth ...

Stéphane Bancel, CEO of mRNA specialist Moderna, delivered some difficult truths to shareholders about the company’s ...

The Evolution Business Park-based University of Cambridge spin-out is on track to achieve revenue growth of more than 300 per ...

Newly declassified British documents show that Queen Elizabeth II wasn’t told details of her long-time art adviser's double ...